Technical Analysis for NEXI - NexImmune, Inc.

Grade Last Price % Change Price Change
F 0.22 5.77% 0.01
NEXI closed down 17.79 percent on Tuesday, November 19, 2024, on approximately normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
50 DMA Resistance Bearish 5.77%
Fell Below 20 DMA Bearish 5.77%
Stochastic Reached Oversold Weakness 5.77%
Wide Bands Range Expansion 5.77%
Oversold Stochastic Weakness 5.77%
50 DMA Resistance Bearish -13.04%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -13.04%
Earnings Movers Other -13.04%
Wide Bands Range Expansion -13.04%
Fell Below 50 DMA Bearish -13.04%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 17 hours ago
2x Volume Pace about 21 hours ago
1.5x Volume Pace about 21 hours ago
3x Volume Pace about 21 hours ago
Up 5% about 21 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation (AIM) technology. The company has two product candidates in human trials, including NEXI-001 in acute myeloid leukemia, or AML; and NEXI-002 in multiple myeloma, or MM. NexImmune, Inc. was founded in 2011 and is headquartered in Gaithersburg, Maryland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Immunotherapy Acute Myeloid Leukemia Immunotherapies Leukemia Multiple Myeloma Immune Mediated Diseases

Is NEXI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.6949
52 Week Low 0.2
Average Volume 3,284
200-Day Moving Average 3.19
50-Day Moving Average 0.28
20-Day Moving Average 0.25
10-Day Moving Average 0.24
Average True Range 0.08
RSI (14) 43.50
ADX 37.26
+DI 40.01
-DI 14.95
Chandelier Exit (Long, 3 ATRs) 0.18
Chandelier Exit (Short, 3 ATRs) 0.44
Upper Bollinger Bands 0.33
Lower Bollinger Band 0.16
Percent B (%b) 0.27
BandWidth 69.92
MACD Line -0.02
MACD Signal Line -0.03
MACD Histogram 0.0094
Fundamentals Value
Market Cap 270.92 Thousand
Num Shares 1.3 Million
EPS -42.05
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.00
Price-to-Book 1.42
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.34
Resistance 3 (R3) 0.35 0.32 0.32
Resistance 2 (R2) 0.32 0.29 0.32 0.31
Resistance 1 (R1) 0.27 0.27 0.25 0.25 0.30
Pivot Point 0.24 0.24 0.23 0.23 0.24
Support 1 (S1) 0.18 0.20 0.16 0.17 0.11
Support 2 (S2) 0.15 0.18 0.14 0.11
Support 3 (S3) 0.09 0.15 0.10
Support 4 (S4) 0.08